Position in FTRE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$136,269
New position
Shares Held
14,466
first reported quarter
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Numerai GP LLC holds $4,852,067 across 6 Biotechnology names. FTRE ranks #5 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
13,984 | $2,643,675 | |
| 2 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
175,670 | $1,076,857 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,641 | $510,448 | |
| 4 | SEPN |
Septerna, Inc.
|
15,082 | $362,420 | |
| 5 | FTRE |
Fortrea Holdings Inc.
This page
|
14,466 | $136,269 | |
| 6 | ARVN |
Arvinas, Inc.
|
11,547 | $122,398 |
All Filings in FTRE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $136,269 | 14,466 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||